Apollomics Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC) Posted on 2023-11-282024-03-13 by maxproadmin More >>
Apollomics Apollomics Announces the First Approval of Vebreltinib for MET Exon 14 Skip Non-Small Cell Lung Cancer Posted on 2023-11-162024-03-13 by maxproadmin More >>
Arthrosi ARTHROSI TO PRESENT POSITIVE PHASE 2 DATA FOR ITS NOVEL SELECTIVE URAT1 INHIBITOR AR882 IN PATIENTS WITH TOPHACEOUS GOUT AT ACR CONVERGENCE 2023 Posted on 2023-11-072024-03-13 by maxproadmin More >>